Zus Health Secures $33M in Series B Funding to Build AI-Powered Clinical Workflows

The latest funding brings Zus Health's total capital raised to more than $100 million. The company will use the investment to advance its intelligent patient record platform, expand its nationwide healthcare data network and develop AI-powered clinical workflows.

Zus Health, the health technology company founded by Jonathan Bush, has raised $33 million in Series B funding to expand its healthcare data infrastructure and develop AI-powered clinical workflows. The round was led by Drive Capital, with participation from Sanofi Ventures, HealthX Ventures, Alumni Ventures and existing investors Andreessen Horowitz (a16z), F-Prime, Maverick Ventures and JAZZ Venture Partners.

The latest funding brings Zus Health's total capital raised to more than $100 million. The company will use the investment to advance its intelligent patient record platform, expand its nationwide healthcare data network and develop AI-powered clinical workflows.

Founded in 2021, Zus Health has built an API-first, FHIR-native medical record platform designed to consolidate fragmented patient information into a continuously updated longitudinal health record. Its platform connects data from EHR networks, pharmacies, laboratories, care event notifications and other clinical sources, making patient information accessible through APIs, standalone applications, embedded components and direct EHR integrations.

The company's Zus Aggregated Profile (ZAP) combines fragmented clinical information into a unified patient record, supported by AI-powered clinical intelligence. The platform is designed to help healthcare organizations access a more complete view of patients without building their own data connectivity infrastructure.

According to Bush, the company has developed its platform in three layers: a nationwide patient record, a data network that continuously feeds information into the record, and AI-enabled workflows that automate care-related tasks.

"Electronic health record systems (EHRs) succeeded at digitizing healthcare but failed to make patient information portable across organizations," Bush, founder and CEO of Zus Health, told Fierce Healthcare.

The company currently works with value-based care organizations, digital health companies, provider organizations, and diagnostics and precision medicine companies. Its solutions support pre-visit preparation, transitions of care, risk adjustment, quality gap closure and population health management.

Zus reported that its nationwide network supported more than 110 million networked transactions in August, while its AI-native clinical platform generated 39 million evidence citations year-to-date across its solutions.

The company is also seeing growth in specialty care, particularly oncology, where patient records are often distributed across multiple providers. Its aggregated patient data is being used to support treatment eligibility reviews, clinical trial criteria assessments and genetic testing, reducing the manual effort involved in reviewing fragmented records.

"We believe healthcare is entering a new era in which AI can fundamentally change how care is delivered, but that transformation depends on having reliable, connected patient information," said Molly Bonakdarpour, general partner at Drive Capital, in a statement.

With the new funding, Zus plans to expand its data network connectivity and AI-powered clinical intelligence capabilities. It also aims to develop additional workflows for population health and care management, value-based care and specialty care.

Stay tuned for more such updates on Digital Health News